FinSMEs / finsmes - Rivia, a Zurich, Switzerland-based provider of a clinical trial data engine and AI platform, raised $15m in Series A funding. The round was led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital. The company int…
Back to Top / Wednesday, March 18, 2026, 11:20 am / permalink 20929 / 4 stories in 3 hrs
Waiv raises $33M to scale AI precision testing for cancer diagnostics / 6 days
Barcelona’s Biorce Secures Series A Funding for AI Clinical Trials Expansion / 6 wks
OpenEvidence secures $250M funding, doubles valuation to $12B / 7 wks
Welsh biotech Antiverse raises $9.3M to advance AI-designed antibodies / 15 days
Mos Health secures fresh funding for AI-driven preventive care / 6 wks
Ahead Health Secures $6M for AI-Powered Early Disease Detection / 2 months
Anthropic expands healthcare services with new AI chatbot capabilities amid competitive pressure / 2 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.